Celator, Science Applications International Corp., National Cancer Institute deal

NCI contractor SAIC-Frederick Inc. will conduct preclinical studies of Celator's hydrophobic docetaxel prodrug nanoparticle formulation for cancer. SAIC-Frederick, a subsidiary of Science Applications...